Form 4 for CVS CVS Health
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001127602-25-011388 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-03 | 2025-04-01 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $67.98 | +11.8K | 95.3K | +14% | +$800.0K |
| D | 2025-04-03 | 2025-04-01 | CVS | CAPOZZI HEIDI B | EVP, CHRO | A - Grant | $67.98 | +49.9K | 49.9K | New | +$3.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2025-04-01 | A | A | 11,768 | $67.98 | 95,310 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-04-01 | A | A | 49,906 | $67.98 | 49,906 | D | $67.98 · 2026-04-01 to 2035-04-01 | 49,906 Common Stock | (F2) Option becomes exercisable in four equal annual installments, commencing on 4/1/2026. |